发明名称 Dihydromyricetin as an IKK-beta inhibitor used for treatment of arthritis, cancer and autoimmune conditions, and other diseases or disorders
摘要 Use of dihydromyricetin (DMY) as an NF-&kgr;B inhibitor or an IKK-&bgr; inhibitor for the treatment of arthritis, cancer, autoimmune conditions and other disease is provided. A pharmaceutical composition comprising DMY is also provided.
申请公布号 US2012053235(A1) 申请公布日期 2012.03.01
申请号 US201113197768 申请日期 2011.08.03
申请人 LIU LIANG;ZHOU HUA;LI TING;WONG KAM WAI;JIANG ZHI HONG;HONG KONG BAPTIST UNIVERSITY 发明人 LIU LIANG;ZHOU HUA;LI TING;WONG KAM WAI;JIANG ZHI HONG
分类号 A61K31/35;A61P1/04;A61P3/10;A61P5/14;A61P7/02;A61P7/06;A61P11/00;A61P11/06;A61P17/00;A61P17/06;A61P19/02;A61P19/04;A61P19/06;A61P25/14;A61P25/16;A61P25/28;A61P29/00;A61P35/00;A61P37/00;A61P37/06;A61P37/08 主分类号 A61K31/35
代理机构 代理人
主权项
地址